GSK plc (GSK,GSK.L), a biopharmaceutical company, on Monday announced that it has appointed Luke Miels as Chief Executive Officer, effective from January 1.
Chief Commercial Officer Luke Miels will take over from Dame Emma Walmsley.
Luke Miels joined the company in 2017 and has previously worked in various senior leadership roles, including at AstraZeneca, Roche and Sanofi-Aventis.
The company said it is operating at a stronger level, with long-term growth targets that include projected sales of over 40 billion pounds by 2031, and noted that 2026 will mark the beginning of a crucial new phase to achieve these goals.
Dame Emma Walmsley said that, "2026 is a pivotal year for GSK to define its path for the decade ahead, and I believe the right moment for new leadership."
On Friday, GSK closed trading 1.05% higher at 1,486 on the London Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.